United States Drug Enforcement Administration

Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...

WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. Under the final rule published today, DEA registrants who are authorized to dispense methadone...

SAN DIEGO – The Drug Enforcement Administration San Diego Field Division presented awards to several federal prosecutors for their exemplary service and dedication to DEA’s mission in San Diego and the surrounding counties. “It was an honor and a privilege to recognize these Assistant U.S. Attorneys along with U.S. Attorney...

WASHINGTON – With the unprecedented worldwide health emergency brought on by COVID-19, last year was filled with new challenges and increased risks. While much of the world focused on combating the pandemic, DEA continued to implement initiatives to combat violent drug traffickers who were intent on flooding cities and rural...

WASHINGTON – Drug Enforcement Administration Acting Administrator Timothy J. Shea today announced that the DEA will direct resources to help reduce violent crime in communities throughout the country. Under this initiative, called Project Safeguard, DEA will identify and prioritize ongoing drug trafficking investigations with a nexus to violent crime. “D...

WASHINGTON – Today, the Department of Justice, through the Joint Criminal Opioid and Darknet Enforcement team, joined Europol to announce the results of Operation DisrupTor, a coordinated international effort to disrupt opioid trafficking on the Darknet. The operation, which was conducted across the United States and Europe, demonstrates the continued...

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...